The Allstate Co. (NYSE:ALL) Shares Purchased by Summit Trail Advisors LLC

Summit Trail Advisors LLC increased its holdings in shares of The Allstate Co. (NYSE:ALL) by 6.8% during the third quarter, HoldingsChannel.com reports. The fund owned 19,573 shares of the insurance provider’s stock after buying an additional 1,245 shares during the period. Summit Trail Advisors LLC’s holdings in Allstate were worth $3,730,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of ALL. SPC Financial Inc. boosted its holdings in shares of Allstate by 3.6% in the 3rd quarter. SPC Financial Inc. now owns 1,564 shares of the insurance provider’s stock valued at $297,000 after buying an additional 54 shares in the last quarter. Lake Street Advisors Group LLC boosted its holdings in shares of Allstate by 1.8% in the 3rd quarter. Lake Street Advisors Group LLC now owns 3,129 shares of the insurance provider’s stock valued at $596,000 after buying an additional 54 shares in the last quarter. Abacus Planning Group Inc. boosted its holdings in shares of Allstate by 2.4% in the 3rd quarter. Abacus Planning Group Inc. now owns 2,416 shares of the insurance provider’s stock valued at $458,000 after buying an additional 56 shares in the last quarter. Chicago Partners Investment Group LLC boosted its holdings in shares of Allstate by 1.3% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider’s stock valued at $893,000 after buying an additional 59 shares in the last quarter. Finally, Carmichael Hill & Associates Inc. boosted its holdings in shares of Allstate by 15.0% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider’s stock valued at $87,000 after buying an additional 60 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Allstate Stock Up 0.2 %

ALL stock opened at $203.80 on Friday. The Allstate Co. has a one year low of $134.17 and a one year high of $205.35. The stock has a market capitalization of $53.97 billion, a PE ratio of 13.20, a price-to-earnings-growth ratio of 1.81 and a beta of 0.48. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The company has a fifty day moving average of $191.41 and a 200-day moving average of $177.84.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. The business had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The business’s revenue was up 14.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.81 EPS. As a group, analysts expect that The Allstate Co. will post 16.07 EPS for the current year.

Allstate Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be issued a $0.92 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.81%. Allstate’s dividend payout ratio is presently 23.83%.

Insider Activity

In other news, insider John E. Dugenske sold 36,367 shares of the stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. This trade represents a 57.06 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 1.80% of the company’s stock.

Analyst Upgrades and Downgrades

ALL has been the subject of several research analyst reports. Bank of America upped their target price on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a report on Friday, October 18th. Piper Sandler increased their price target on shares of Allstate from $188.00 to $196.00 and gave the stock an “overweight” rating in a research note on Friday, August 16th. Keefe, Bruyette & Woods increased their price target on shares of Allstate from $222.00 to $225.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 6th. StockNews.com cut shares of Allstate from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 21st. Finally, UBS Group increased their price target on shares of Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. One analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $214.19.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.